Helping pregnant people make decisions about genetic testing
Treatments studied
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study is for pregnant people who were offered prenatal genetic testing. It aims to help them make informed decisions about these tests, with the goal of improving pregnancy outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and speak English.
- You are willing to give your consent to be in the study.
- You were offered routine prenatal genetic screening or diagnostic testing.
- You are 18 years old or older.
- You are currently pregnant (with an intrauterine pregnancy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a chatbot that helps pregnant women think about prenatal genetic tests. You can join if you are early in pregnancy, have a phone or tablet, and haven't already talked to a genetic counselor about this pregnancy.
This study helps pregnant people make informed choices about genetic screening tests by providing clear, timely information. Researchers want to learn the best way to explain screening options so you can decide what's right for you and your family.
This research study helps pregnant people understand the results of genetic tests done during pregnancy (like CVS or amniocentesis). The study follows families for one year after birth to learn how genetic counseling and test results affect decision-making and family wellbeing.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
This study is testing a non-invasive prenatal blood test (NIPD) that can check for certain serious genetic disorders in your baby, instead of using more invasive methods like amniocentesis. If you are at risk of passing on a severe genetic condition, this test may help you get answers safely.
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
Hear when a new Prenatal Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.